您的位置: 首页 > 农业专利 > 详情页

LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS
专利权人:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人:
KNAPPERTZ, VOLKER,KAYE, JOEL
申请号:
SG11201602175V
公开号:
SG11201602175VA
申请日:
2014.09.26
申请国别(地区):
SG
年份:
2016
代理人:
摘要:
The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I): as described herein. The subject invention also provides packages and pharmaceutical compositions comprising laquinimod and a compound of formula (I) as described herein. The subject invention further provides uses of said compounds, pharmaceutical compositions and packages in treating a subject afflicted with a form of MS or presenting a CIS.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充